September 5, 2018 Alexandros Morelas Potent new chemical causes brain cancer cells to ‘self-destruct’, early trial shows
August 8, 2018 Alexandros Morelas FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation
